Cleared Traditional

K234076 - iCare ALTIUS CW

K234076 is an FDA 510(k) clearance for iCare ALTIUS CW, manufactured by Centervue S.P.A.. The device is a Class 2 Ophthalmic device with product code NFJ cleared through the Traditional 510(k) pathway after a 245-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
245d
Days
Class 2
Risk

K234076 is an FDA 510(k) clearance for the iCare ALTIUS CW. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Centervue S.P.A. (Padova, IT). The FDA issued a Cleared decision on August 22, 2024 after a review of 245 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Centervue S.P.A. devices

FDA 510(k) Submission Details - K234076

510(k) Number K234076 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2023
Decision Date August 22, 2024
Days to Decision 245 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
135d slower than avg
Panel avg: 110d · This submission: 245d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFJ Device Classification - Class 2, Special Controls

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 34
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K234076.
ZEISS CLINIC 360
K260694 · Carl Zeiss Meditec, AG · Jul 2026
Harmony Referral System with Harmony OCT Viewer (Octave)
K253893 · Topcon Healthcare Solutions EMEA Oy · Jun 2026
IMAGEnet6 Ophthalmic Data System
K232828 · Topcon Corporation · Mar 2024
CALLISTO eye
K232944 · Carl Zeiss Meditec, AG · Dec 2023
Harmony
K232555 · Topcon Healthcare Solutions · Nov 2023
CALLISTO eye
K231676 · Carl Zeiss Meditec, AG · Aug 2023